Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
- Eargo, Inc. (NASDAQ: EAR) shares climbed 50.4% to $2.5274 after the company announced it will be taken private by Patient Square Capital.
- VYNE Therapeutics Inc. (NASDAQ: VYNE) gained 39.9% to $3.1399 after the company announced a private placement of $88 million and data from its Phase 1b trial evaluating once-daily dosing of VYN201 in patients with nonsegmental vitiligo.
- Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares gained 27.9% to $1.3042 after falling more than 12% on Friday.
- HeartCore Enterprises, Inc. (NASDAQ: HTCR) surged 24% to $0.7718. Heartcore Enterprises recently entered into at-market offering agreement for an at-market offering with H.C. Wainwright & Co.
- ImmunityBio, Inc. (NASDAQ: IBRX) gained 19.4% to $2.9600. The FDA recently accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete.
- Coherus BioSciences, Inc. (NASDAQ: CHRS) shares climbed 16.8% to $3.0850. Coherus and Junshi Biosciences reported FDA approval of LOQTORZI in all lines of treatment for recurrent or metastatic nasopharyngeal carcinoma.
- Aemetis, Inc. (NASDAQ: AMTX) gained 16.5% to $5.02. Aemetis received $150 million biodiesel supply allocation from India oil marketing companies.
- JinkoSolar Holding Co., Ltd. (NYSE: JKS) surged 16% to $30.01 following better-than-expected quarterly results.
- Akerna Corp. (NASDAQ: KERN) jumped 16% to $0.3550.
- MeiraGTx Holdings plc (NASDAQ: MGTX) rose 16% to $4.29. MeiraGTx announced a $30 million strategic investment from Sanofi via purchase of 4 million shares at $7.50 per share.
- Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 15.6% to $0.4742 after declining 11% on Friday. The company recently received FDA clearance to commercialize Pure-Vu EVS Gastro and Gen 4 Colon.
- Global Mofy Metaverse Limited (NASDAQ: GMM) jumped 15.4% to $12.10.
- My Size, Inc. (NASDAQ: MYSZ) shares gained 15.1% to $0.8059.
- Daqo New Energy Corp. (NYSE: DQ) gained 15% to $26.82 following quarterly results.
- Save Foods, Inc. (NASDAQ: SVFD) rose 14.8% to $2.3369.
- Lumentum Holdings Inc. (NASDAQ: LITE) gained 13.3% to $40.85.
- Safety Shot, Inc. (NASDAQ: SHOT) rose 12.8% to $1.32. The company announced the direct-to-consumer launch of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, in the first week of Dec. 2023.
- XPO, Inc. (NYSE: XPO) gained 12.2% to $75.54 after the company reported better-than-expected third-quarter financial results.
- HUTCHMED (China) Limited (NASDAQ: HCM) surged 12.2% to $20.73.
- BeiGene, Ltd. (NASDAQ: BGNE) gained 11.2% to $189.60. BeiGene recently said BRUKINSA received a positive recommendation from NICE in the UK for adult patients with chronic lymphocytic leukemia.
- Western Digital Corporation (NASDAQ: WDC) climbed 10.3% to $42.99 after the company reported first-quarter results and announced a plan to separate its HDD and Flash businesses.
- Color Star Technology Co., Ltd. (NASDAQ: ADD) surged 9% to $0.2845.
- Intuitive Machines, Inc. (NASDAQ: LUNR) gained 6.2% to $2.8350 as the company said that in coordination with SpaceX, liftoff of the IM-1 lunar mission is now targeted for a multi-day launch window which opens Jan. 12, 2024.
- CommScope Holding Company, Inc. (NASDAQ: COMM) shares fell 32.2% to $1.64 after the company reported preliminary third-quarter financial results.
- LumiraDx Limited (NASDAQ: LMDX) declined 30.5% to $0.0833. On Oct. 24, LumiraDx announced receipt of Nasdaq delisting determination.
- Alzamend Neuro, Inc. (NASDAQ: ALZN) fell 30.1% to $0.1216 after the company announced a reverse stock split.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) fell 23.4% to $1.24.
- Aehr Test Systems (NASDAQ: AEHR) declined 23.5% to $22.80.
- Tenax Therapeutics, Inc. (NASDAQ: TENX) fell 21.9% to $0.1975.
- Biophytis (NASDAQ: BKYI) dipped 20.2% to $0.1755 after jumping over 28% on Friday. BIO-Key International recently posted a narrower quarterly loss.
- Better Therapeutics, Inc. (NASDAQ: BTTX) fell 18.5% to $0.1511.
- ON Semiconductor Corporation (NASDAQ: ON) fell 18.4% to $68.14 after the company reported third-quarter financial results and issued fourth-quarter adjusted EPS and revenue guidance below estimates.
- Revvity, Inc. (NYSE: RVTY) declined 18.2% to $80.00 after the company reported worse-than-expected third-quarter results lowered its FY23 guidance.
- Forbion European Acquisition Corp. (NASDAQ: FRBN) fell 15.5% to $24.01.
- Aptose Biosciences Inc. (NASDAQ: APTO) dipped 14.2% to $2.7450.
- Seelos Therapeutics, Inc. (NASDAQ: SEEL) fell 13.9% to $0.1781.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) declined 13.8% to $0.8792.
- Nuvve Holding Corp. (NASDAQ: NVVE) shares fell 12.7% to $0.1876 after declining over 8% on Friday. Nuvve recently announced pricing of a $2.066 million registered direct offering priced at-the-market.
- Marine Products Corporation (NYSE: MPX) declined 11% to $9.91. Marine Products recently reported worse-than-expected third-quarter financial results.
- Axcelis Technologies, Inc. (NASDAQ: ACLS) fell 10.4% to $123.70.
- Fisker Inc. (NYSE: FSR) fell 10.1% to $4.3050.
- MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares fell 9.2% to $0.54.
- Align Technology, Inc. (NASDAQ: ALGN) fell 7% to $177.59.
- Dana Incorporated (NYSE: DAN) declined 6.3% to $11.83.
- NXP Semiconductors N.V. (NASDAQ: NXPI) fell 6.2% to $168.10.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.